NASDAQ:HSTO Histogen (HSTO) Stock Price, News & Analysis → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free HSTO Stock Alerts $0.35 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$0.35▼$0.4050-Day Range$0.15▼$0.5052-Week Range$0.05▼$1.05Volume6,956 shsAverage Volume17,945 shsMarket Capitalization$1.49 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsSocial Media Get Histogen alerts: Email Address Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. About Histogen Stock (NASDAQ:HSTO)Histogen Inc., a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body's natural process to restore immune function. The company's product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases. Its preclinical product candidates include CTS-2090 and CTS-2096, which are selective small molecule inhibitors of caspase-1 designed for the treatment of various inflammatory diseases. Histogen Inc. was founded in 2007 and is based in San Diego, California.Read More HSTO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HSTO Stock News HeadlinesApril 22, 2024 | finanznachrichten.deHistogen Inc: Histogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share OfferingApril 18, 2024 | markets.businessinsider.comHistogen Files For Voluntary Chapter 11 Bankruptcy ProtectionApril 25, 2024 | InvestorPlace (Ad)The Next Nvidia?The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.April 18, 2024 | msn.comHistogen files for Chapter 11, seeks liquidationApril 18, 2024 | globenewswire.comHistogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share OfferingFebruary 6, 2024 | benzinga.comHistogen Stock (OTC:HSTO) Dividends: History, Yield and DatesDecember 14, 2023 | finance.yahoo.comHistogen Announces Second Adjournment of Special Meeting of StockholdersDecember 6, 2023 | finanznachrichten.deHistogen Inc: Histogen Announces Adjournment of Special Meeting of StockholdersApril 25, 2024 | InvestorPlace (Ad)The Next Nvidia?The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.December 5, 2023 | finance.yahoo.comHistogen Announces Adjournment of Special Meeting of StockholdersNovember 1, 2023 | morningstar.comHistogen Inc HSTOSeptember 21, 2023 | msn.comWall Street Set to Open Wednesday Trading Higher as Investors Await Fed Decision on Interest RatesSeptember 20, 2023 | msn.comU.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.31%September 20, 2023 | finanznachrichten.deHistogen Inc: Histogen Announces Board Approval of Complete Liquidation and DissolutionSeptember 20, 2023 | markets.businessinsider.comHistogen Board Approves To Dissolve And Wind Down OperationsSeptember 19, 2023 | msn.comU.S. shares lower at close of trade; Dow Jones Industrial Average down 0.31%September 18, 2023 | msn.comBiotech firm Histogen to wind down after failing to raise capitalSeptember 18, 2023 | finance.yahoo.comHistogen Announces Board Approval of Complete Liquidation and DissolutionJuly 6, 2023 | benzinga.comHistogen shares are trading higher after the company decided to pause further development of its programs, commence exploring strategic alternatives.July 5, 2023 | seekingalpha.comHistogen plans to commence strategic alternatives processJuly 5, 2023 | finance.yahoo.comHistogen to Explore Strategic AlternativesMay 11, 2023 | finance.yahoo.comHistogen Reports First Quarter 2023 Results and Provides Business UpdateApril 20, 2023 | finance.yahoo.comHistogen Announces Online Publication in the Journal of Investigative DermatologyApril 3, 2023 | finance.yahoo.comHistogen Announces Exclusive Intellectual Property License Agreement with Johns Hopkins UniversityMarch 20, 2023 | benzinga.comShort Volatility Alert: Histogen IncMarch 17, 2023 | investorplace.comWhy Is Histogen (HSTO) Stock Up 37% Today?March 16, 2023 | finance.yahoo.comHistogen Announces Issuance of US Patent Covering CTS-2090 Methods of UseSee More Headlines Receive HSTO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Histogen and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/10/2021Today4/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:HSTO CUSIPN/A CIK1383701 Webwww.histogen.com Phone(858) 526-3100FaxN/AEmployees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.81) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,620,000.00 Net Margins-65,142.11% Pretax Margin-65,178.96% Return on Equity-136.13% Return on Assets-90.87% Debt Debt-to-Equity RatioN/A Current Ratio4.05 Quick Ratio4.05 Sales & Book Value Annual Sales$3.77 million Price / Sales0.40 Cash FlowN/A Price / Cash FlowN/A Book Value$3.13 per share Price / Book0.11Miscellaneous Outstanding Shares4,270,000Free Float4,131,000Market Cap$1.49 million OptionableNot Optionable Beta0.92 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMs. Susan A. Knudson (Age 60)President, CEO, CFO, COO, Chief Compliance Officer & Corporate Secretary Comp: $653.2kKey CompetitorsPanbela TherapeuticsNASDAQ:PBLAGRI BioNASDAQ:GRINeuBase TherapeuticsNASDAQ:NBSE180 Life SciencesNASDAQ:ATNFInMed PharmaceuticalsNASDAQ:INMView All Competitors HSTO Stock Analysis - Frequently Asked Questions How have HSTO shares performed in 2024? Histogen's stock was trading at $0.3077 at the beginning of 2024. Since then, HSTO stock has increased by 13.8% and is now trading at $0.3501. View the best growth stocks for 2024 here. How were Histogen's earnings last quarter? Histogen Inc. (NASDAQ:HSTO) posted its quarterly earnings results on Wednesday, November, 10th. The company reported ($1.80) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.20) by $0.40. The company had revenue of $0.59 million for the quarter. Histogen had a negative trailing twelve-month return on equity of 136.13% and a negative net margin of 65,142.11%. During the same period last year, the business earned ($5.40) earnings per share. When did Histogen's stock split? Histogen shares reverse split on Friday, June 3rd 2022. The 1-20 reverse split was announced on Friday, June 3rd 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, June 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What other stocks do shareholders of Histogen own? Based on aggregate information from My MarketBeat watchlists, some companies that other Histogen investors own include Carnival Co. & (CCL), Intel (INTC), Genius Brands International (GNUS), Gilead Sciences (GILD), Clovis Oncology (CLVS), B2Gold (BTG), BIOLASE (BIOL), (BBI.V) (BBI), Advanced Micro Devices (AMD) and Akers Biosciences (AKER). How do I buy shares of Histogen? Shares of HSTO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:HSTO) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Histogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
